A multidisciplinary Delphi consensus on budesonide aqueous nasal spray in managing upper respiratory diseases DOI Creative Commons
Giorgio Ciprandi, Ignazio La Mantia, Attilio Varricchio

и другие.

Multidisciplinary Respiratory Medicine, Год журнала: 2025, Номер 20(Vol. 20 (2025))

Опубликована: Март 3, 2025

Allergic rhinitis (AR), non-allergic (NAR), and chronic rhinosinusitis with nasal polyps (CRSwNP) share a type 2 inflammation. Thus, intranasal corticosteroids (INCS) are recommended for managing these diseases. In this regard, budesonide aqueous spray (BANS) has been an effective safe INCS available decades. As recent Delphi consensus survey explored the use of topical therapy in practice, panel experts promoted multidisciplinary on BANS daily practice. Forty-six Italian expert otorhinolaryngologists, allergologists, pediatricians participated initiative. Twenty-one statements were voted on. There was large agreement all statements. document proposed valuable patients AR, NAR, or CRSwNP considering relevant activity dampening Moreover, safety profile considered good, also concerning bioavailability issue. However, based severity disease, should be prescribed as cycles prolonged periods. conclusion, present supported upper airway

Язык: Английский

A multidisciplinary Delphi consensus on budesonide aqueous nasal spray in managing upper respiratory diseases DOI Creative Commons
Giorgio Ciprandi, Ignazio La Mantia, Attilio Varricchio

и другие.

Multidisciplinary Respiratory Medicine, Год журнала: 2025, Номер 20(Vol. 20 (2025))

Опубликована: Март 3, 2025

Allergic rhinitis (AR), non-allergic (NAR), and chronic rhinosinusitis with nasal polyps (CRSwNP) share a type 2 inflammation. Thus, intranasal corticosteroids (INCS) are recommended for managing these diseases. In this regard, budesonide aqueous spray (BANS) has been an effective safe INCS available decades. As recent Delphi consensus survey explored the use of topical therapy in practice, panel experts promoted multidisciplinary on BANS daily practice. Forty-six Italian expert otorhinolaryngologists, allergologists, pediatricians participated initiative. Twenty-one statements were voted on. There was large agreement all statements. document proposed valuable patients AR, NAR, or CRSwNP considering relevant activity dampening Moreover, safety profile considered good, also concerning bioavailability issue. However, based severity disease, should be prescribed as cycles prolonged periods. conclusion, present supported upper airway

Язык: Английский

Процитировано

0